GSA Capital Partners LLP boosted its holdings in shares of Castlight Health, Inc. (NYSE:CSLT) by 49.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 126,151 shares of the software maker’s stock after buying an additional 41,757 shares during the quarter. GSA Capital Partners LLP’s holdings in Castlight Health were worth $164,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the business. BlackRock Inc. lifted its holdings in Castlight Health by 5.4% during the 3rd quarter. BlackRock Inc. now owns 3,246,767 shares of the software maker’s stock worth $3,669,000 after buying an additional 167,680 shares in the last quarter. Royce & Associates LP raised its holdings in shares of Castlight Health by 1.3% in the 3rd quarter. Royce & Associates LP now owns 2,379,034 shares of the software maker’s stock valued at $2,688,000 after purchasing an additional 30,000 shares in the last quarter. Acadian Asset Management LLC raised its holdings in shares of Castlight Health by 33.8% in the 3rd quarter. Acadian Asset Management LLC now owns 2,227,836 shares of the software maker’s stock valued at $2,516,000 after purchasing an additional 563,011 shares in the last quarter. Perkins Capital Management Inc. acquired a new stake in shares of Castlight Health in the 3rd quarter valued at $1,385,000. Finally, Squarepoint Ops LLC raised its holdings in shares of Castlight Health by 65.8% in the 3rd quarter. Squarepoint Ops LLC now owns 650,958 shares of the software maker’s stock valued at $736,000 after purchasing an additional 258,319 shares in the last quarter. Institutional investors own 46.22% of the company’s stock.
In related news, CEO Maeve O’meara sold 59,615 shares of Castlight Health stock in a transaction on Wednesday, February 17th. The shares were sold at an average price of $1.89, for a total transaction of $112,672.35. Following the sale, the chief executive officer now directly owns 1,243,988 shares in the company, valued at approximately $2,351,137.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Seth B. Cohen sold 30,000 shares of Castlight Health stock in a transaction on Monday, December 28th. The stock was sold at an average price of $1.50, for a total transaction of $45,000.00. Following the sale, the director now owns 372,761 shares in the company, valued at $559,141.50. The disclosure for this sale can be found here. Insiders have sold a total of 176,421 shares of company stock worth $322,516 over the last quarter. 17.05% of the stock is owned by company insiders.
CSLT has been the topic of a number of analyst reports. Zacks Investment Research upgraded shares of Castlight Health from a “hold” rating to a “buy” rating and set a $1.75 price objective on the stock in a report on Thursday, January 28th. Canaccord Genuity raised their price objective on shares of Castlight Health from $1.00 to $2.00 and gave the company a “hold” rating in a report on Thursday, February 11th.
Castlight Health Profile
Castlight Health, Inc provides health navigation solutions for employers and health plan customers in education, manufacturing, retail, technology, and government industries in the United States. It provides Care Guidance Navigator that enables users to make care decisions and navigate the employer-sponsored healthcare benefit programs; Wellbeing Navigator, which helps to drive engagement across an employer's benefits program; and Complete Health Navigator that combines the Wellbeing Navigator and Care Guidance Navigator packages for unified user experience.
Read More: Balanced Fund
Want to see what other hedge funds are holding CSLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Castlight Health, Inc. (NYSE:CSLT).
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.